Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Aug 06, 2015

Mylan Second Quarter 2015 Constant Currency Revenue Increases 36% and Adjusted Diluted EPS Increases 32% to $0.91

Aug 05, 2015

Mylan Launches Generic Nexium® Delayed-Release Capsules

Aug 05, 2015

Mylan Provides Update on Conditions to Perrigo Offer

Jul 29, 2015

Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo

Jul 27, 2015

Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders

Jul 27, 2015

Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit

Jul 24, 2015

Mylan Schedules Second Quarter 2015 Financial Results Conference Call and Live Webcast

Jul 23, 2015

Mylan Acknowledges Exercise of Full Call Option by the Independent Foundation

Jul 14, 2015

Mylan One of First to Launch Generic Version of Namenda® Tablets

Jul 13, 2015

Market Withdrawal: Calcium Chloride Intravenous Infusion 10% w/v – 10mL (Prefilled Syringe)

Pagination

First page
Previous page
…
Page 33
Page 34
Page 35
Page 36
Current page 37
Page 38
Page 39
Page 40
Page 41
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.